Lawmakers Push Back on Amodei’s Call for an AI-Safety Antitrust Waiver
Opponents distinguish shared safety standards from agreements to slow competition. A bipartisan bill would explicitly permit coordination to limit high-risk model deployments.
Loading page…
Opponents distinguish shared safety standards from agreements to slow competition. A bipartisan bill would explicitly permit coordination to limit high-risk model deployments.
Listen to this story
The dispute is over whether AI companies need new legal cover to coordinate on safety—not whether safety cooperation is allowed. After Anthropic CEO Dario Amodei called for a narrow antitrust waiver, Sen. Elizabeth Warren and former Justice Department antitrust chief Jonathan Kanter said existing law permits sharing threat information and setting safer-product standards, while joint decisions to slow innovation could cross into anticompetitive conduct. A bipartisan bill would go further by protecting coordination to delay or limit deployment of high-risk models, a scope lawmakers remain divided over.
The bipartisan bill would protect both AI security information-sharing and coordination to delay or limit deployment of high-risk models.
Rep. Sam Liccardo said any protection should be limited to testing, evaluation and training that make models safer.
Sen. Richard Blumenthal backed cooperation under government oversight, while Sen. John Hoeven rejected a blanket exemption.
AI companies seeking permission to cooperate on safety face a pointed objection: some lawmakers and a former top antitrust enforcer say they already can. In September 30 reporting by CNBC, Sen. Elizabeth Warren and former Justice Department antitrust chief Jonathan Kanter rejected the need for the waiver proposed by Anthropic CEO Dario Amodei.
Amodei’s essay, “We Must Pace the Frontier,” urged AI companies to voluntarily establish shared standards. He argued that the U.S. government should mediate or enable those discussions through a narrow waiver for certain safety conversations. The proposal also contemplated collective limits on unchecked AI progress, which Amodei acknowledged could pose legal challenges.
Kanter drew the legal boundary around what competitors agree to do. Companies can exchange information about malicious threats and develop standards for safer products without an exemption, he told CNBC. His objection concerned agreements that would stop companies from innovating or competing, rather than discussions about making their systems safer.
He said companies do not need to make slowdown decisions jointly. He also warned that safety could become a pretext for other anticompetitive coordination. That warning concerns what an exemption might permit; it is not a finding that the companies have already used safety discussions to suppress competition.
Warren likewise said existing antitrust law already contains an exception for companies working together on safety. Sen. Richard Blumenthal said companies do not need a waiver to prevent catastrophic consequences when cooperating under government oversight. Republican Sen. John Hoeven rejected a blanket exemption, citing lawmakers’ dissatisfaction with earlier technology-industry carveouts.
The waiver has congressional supporters, too. Reps. George Whitesides and Bob Latta, along with Sens. Adam Schiff and Jim Banks, carry a bipartisan bill that would create a carveout. CNBC’s description of the bill identifies two forms of protected cooperation:
Rep. Sam Liccardo, who pushed for Whitesides’ bill, said any protection must be narrowly focused on testing, evaluation and training that make models safer. He argued that intense competition gives companies little incentive to collaborate across many other activities. His defense puts the scope of permitted cooperation at the center of the proposal.
Kanter’s opposition to a waiver does not amount to opposition to AI regulation. He separately urged Congress to consider basic rules protecting the public from harmful products and services. His proposed path is government-set safeguards without giving competitors additional permission to make joint business decisions.
Loading discussion...
Join the conversation
Explain whether shared restraint or reduced competition concerns you more.
Be the first to share a perspective or an experience.
Reader comments
Newest comments first. Replies stay oldest first.